Bruntwood SciTech receives planning approval for £60m specialist labs in Manchester Science Park’s third masterplan phase

Progressive plans for the next phase of Manchester Science Park’s masterplan development have today been approved by Manchester City Council. The scheme will see Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General, deliver a £60m redevelopment of the Park’s existing Greenheys building, bringing forward 131,000 sq ft of highly specialist world-class lab space.

The redevelopment by the UK’s leading property provider dedicated to the growth of the science and technology sector forms the third phase of Bruntwood SciTech’s masterplan to grow the science and technology hub to 1m sq ft. It is expected to open in Spring 2026 and follows the completion of its neighbouring building Base, which opened in July 2022 as a new tech hub for the campus. With planning approved, enabling works are due to commence later this summer.

The planning approval follows confirmation that UK Biobank – the world’s most significant source of data and biological samples for health research – will move to Greenheys, adding to and complementing the 150 pioneering, fast-growth SMEs and large market-leading businesses already based at Manchester Science Park. In addition to UK Biobank, commercial space will be available in Greenheys for scaling life science companies to locate alongside them.

Businesses locating to the campus will have direct access to research, talent and new market opportunities with The University of Manchester and Manchester University NHS Foundation Trust, as well as new collaboration opportunities to work with UK Biobank to conduct vital research and enable new scientific discoveries that improve human health.